Konrad Bochennek

1.5k total citations
53 papers, 919 citations indexed

About

Konrad Bochennek is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Konrad Bochennek has authored 53 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 17 papers in Oncology and 15 papers in Infectious Diseases. Recurrent topics in Konrad Bochennek's work include Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (14 papers) and Neutropenia and Cancer Infections (12 papers). Konrad Bochennek is often cited by papers focused on Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (14 papers) and Neutropenia and Cancer Infections (12 papers). Konrad Bochennek collaborates with scholars based in Germany, Austria and United Kingdom. Konrad Bochennek's co-authors include Thomas Klingebiel, Thomas Lehrnbecher, Stefanie Zimmermann, Boris Wittekindt, Andreas H. Groll, Ulrike Koehl, Lars Tramsen, Dirk Schwabe, Ursula Creutzig and Dirk Reinhardt and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Microbiology Reviews and Scientific Reports.

In The Last Decade

Konrad Bochennek

46 papers receiving 899 citations

Peers

Countries citing papers authored by Konrad Bochennek

Since Specialization

Citations

This map shows the geographic impact of Konrad Bochennek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konrad Bochennek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konrad Bochennek more than expected).

Fields of papers citing papers by Konrad Bochennek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konrad Bochennek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konrad Bochennek. The network helps show where Konrad Bochennek may publish in the future.

Co-authorship network of co-authors of Konrad Bochennek

This figure shows the co-authorship network connecting the top 25 collaborators of Konrad Bochennek. A scholar is included among the top collaborators of Konrad Bochennek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konrad Bochennek. Konrad Bochennek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials 2023 ·Cancers ·Lars Tramsen, Konrad Bochennek, Monika Sparber‐Sauer, Emilia Salzmann‐Manrique, Monika Scheer, Tobias M. Dantonello, Arndt Borkhardt, Uta Dirksen, Anne Thorwarth, Jeanette Greiner, Martin Ebinger, (unknown), Ruth Ladenstein, Gustaf Ljungman, Erika Hallmen, Thomas Lehrnbecher, Ewa Kościelniak, Thomas Klingebiel	13
2	Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation 2023 ·Journal of Fungi ·Thomas Lehrnbecher, Konrad Bochennek, Andreas H. Groll	5
3	Therapiestrategien bei Kindern und Jugendlichen mit Langerhanszell Histiozytosen 2023 ·Klinische Pädiatrie ·(unknown), Caroline Hutter, Konrad Bochennek, Milen Minkov, Thomas Lehrnbecher	0
4	No role for electroencephalogram in the initial work-up of pediatric acute lymphoblastic leukemia 2023 ·Supportive Care in Cancer ·(unknown), (unknown), Susanne Schubert‐Bast, Konrad Bochennek, Thomas Lehrnbecher	0
5	Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients—Results from a Prospective Study in Two Major Large European Cancer Centers 2022 ·Antibiotics ·(unknown), (unknown), Konrad Bochennek, (unknown), Andreas H. Groll, Thomas Lehrnbecher	3
6	Multidisciplinary Treatment Strategies for Wilms Tumor: Recent Advances, Technical Innovations and Future Directions 2022 ·Frontiers in Pediatrics ·Till‐Martin Theilen, Yannick Braun, Konrad Bochennek, Udo Rolle, Henning C. Fiegel, Florian Friedmacher	14
7	Antifungal Combination Therapy in Children with Cancer—A 4-Year Analysis of Real-Life Data of Two Major Pediatric Cancer Centers 2021 ·Journal of Fungi ·(unknown), Konrad Bochennek, (unknown), Andreas H. Groll, Thomas Lehrnbecher	0
8	Fieber während der Granulozytopenie bei krebskranken Kindern und Jugendlichen Febrile neutropenia in pediatric and adolescent cancer patients 2021 ·Konrad Bochennek, Arne Simon, H.-J. Laws, Andreas H. Groll, Thomas Lehrnbecher	0
9	An Exponential Regression Model Reveals the Continuous Development of B Cell Subpopulations Used as Reference Values in Children 2018 ·Frontiers in Pediatrics ·Christoph Königs, Stephan Schultze‐Strasser, Andrea Quaiser, Konrad Bochennek, Dirk Schwabe, Thomas Klingebiel, Ulrike Koehl, (unknown), Udo Rolle, Peter Bader, Melanie Bremm, Sabine Huenecke, Shahrzad Bakhtiar	2
10	Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial 2016 ·Journal of Clinical Oncology ·Lars Tramsen, Emilia Salzmann‐Manrique, Konrad Bochennek, Thomas Klingebiel, Dirk Reinhardt, Ursula Creutzig, Lillian Sung, Thomas Lehrnbecher	37
11	Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004 2016 ·Blood Cancer Journal ·Konrad Bochennek, Angela Haßler, (unknown), (unknown), Sonja Schöning, Thomas Klingebiel, Dirk Reinhardt, Ursula Creutzig, Thomas Lehrnbecher	60
12	Role of natural killer cells in antibacterial immunity 2016 ·Expert Review of Hematology ·Stanislaw Schmidt, Evelyn Ullrich, Konrad Bochennek, Stefanie Zimmermann, Thomas Lehrnbecher	20
13	Immune cell subsets at birth may help to predict risk of late-onset sepsis and necrotizing enterocolitis in preterm infants 2015 ·Early Human Development ·Konrad Bochennek, (unknown), Boris Wittekindt, Horst Buxmann, Andrea Quaiser, Doris Fischer, Thomas Klingebiel, Ulrike Koehl, Rolf Schloesser, Sabine Huenecke	15
14	Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients 2011 ·Clinical Microbiology and Infection ·Konrad Bochennek, Lars Tramsen, (unknown), Minerva Becker, Thomas Klingebiel, Andreas H. Groll, Thomas Lehrnbecher	43
15	Detection of Neuroblastoma Cells During Clinical Follow Up: Advanced Flow Cytometry and RT-PCR for Tyrosine Hydroxylase Using Both Conventional and Real-Time PCR 2011 ·Klinische Pädiatrie ·R. Esser, Wolfgang Glienke, Konrad Bochennek, (unknown), Andrea Quaiser, Christian Pieper, Angelika Eggert, Alexander Schramm, Kathy Astrahantseff, Martin‐Leo Hansmann, Dirk Schwabe, T. Klingebiel, Ulrike Koehl	3
16	Age‐matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis 2008 ·European Journal Of Haematology ·Sabine Huenecke, (unknown), (unknown), Stefanie Zimmermann, Konrad Bochennek, Lars Tramsen, Ruth Esser, Dieter Klarmann, (unknown), (unknown), Dorotheé von Laer, Thomas Klingebiel, Thomas Lehrnbecher, Ulrike Koehl	65
17	Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies 2008 ·The Lancet Oncology ·Thomas Lehrnbecher, Ulrike Koehl, Boris Wittekindt, Konrad Bochennek, Lars Tramsen, Thomas Klingebiel, Stephen J. Chanock	32
18	A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells 2007 ·Journal of Immunological Methods ·Stephan Klöß, Konrad Bochennek, Sabine Huenecke, Stefanie Zimmermann, Selim Kuçi, Tina Müller, Winfried S. Wels, Thomas Klingebiel, Ruth Esser, Ulrike Koehl	21
19	More than mere games: a review of card and board games for medical education 2007 ·Medical Teacher ·Konrad Bochennek, Boris Wittekindt, Stefanie Zimmermann, Thomas Klingebiel	131
20	Diagnostic approaches for immunocompromised paediatric patients with pulmonary infiltrates 2006 ·Clinical Microbiology and Infection ·Konrad Bochennek, Nasreddin Abolmaali, Boris Wittekindt, Dirk Schwabe, Thomas Klingebiel, Thomas Lehrnbecher	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact